JP2018522880A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018522880A5 JP2018522880A5 JP2017568234A JP2017568234A JP2018522880A5 JP 2018522880 A5 JP2018522880 A5 JP 2018522880A5 JP 2017568234 A JP2017568234 A JP 2017568234A JP 2017568234 A JP2017568234 A JP 2017568234A JP 2018522880 A5 JP2018522880 A5 JP 2018522880A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- dengue virus
- denv
- composition according
- pfu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021113634A JP2021176862A (ja) | 2015-07-02 | 2021-07-08 | デングウイルス及び樹状細胞による併用療法のための組成物及び方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562231351P | 2015-07-02 | 2015-07-02 | |
| US62/231,351 | 2015-07-02 | ||
| PCT/US2016/040787 WO2017004567A1 (en) | 2015-07-02 | 2016-07-01 | Compositions and methods for combination therapy with dengue virus and dendritic cells |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021113634A Division JP2021176862A (ja) | 2015-07-02 | 2021-07-08 | デングウイルス及び樹状細胞による併用療法のための組成物及び方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018522880A JP2018522880A (ja) | 2018-08-16 |
| JP2018522880A5 true JP2018522880A5 (enExample) | 2019-08-08 |
Family
ID=57609586
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017568234A Pending JP2018522880A (ja) | 2015-07-02 | 2016-07-01 | デングウイルス及び樹状細胞による併用療法のための組成物及び方法 |
| JP2021113634A Pending JP2021176862A (ja) | 2015-07-02 | 2021-07-08 | デングウイルス及び樹状細胞による併用療法のための組成物及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021113634A Pending JP2021176862A (ja) | 2015-07-02 | 2021-07-08 | デングウイルス及び樹状細胞による併用療法のための組成物及び方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (6) | US9730989B2 (enExample) |
| EP (1) | EP3316897A4 (enExample) |
| JP (2) | JP2018522880A (enExample) |
| CN (1) | CN107921063A (enExample) |
| CA (1) | CA2991212A1 (enExample) |
| DE (1) | DE202016008300U1 (enExample) |
| MX (1) | MX2018000052A (enExample) |
| WO (1) | WO2017004567A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017004567A1 (en) | 2015-07-02 | 2017-01-05 | PrimeVax Immuno-Oncology, Inc. | Compositions and methods for combination therapy with dengue virus and dendritic cells |
| MX2018003757A (es) * | 2015-09-26 | 2018-09-21 | Primevax Immuno Oncology Inc | Composiciones y metodos para producir celulas dendriticas. |
| WO2018093907A1 (en) * | 2016-11-16 | 2018-05-24 | PrimeVax Immuno-Oncology, Inc. | Combination immunotherapies for treatment of cancer |
| WO2018129202A1 (en) * | 2017-01-04 | 2018-07-12 | PrimeVax Immuno-Oncology, Inc. | Compositions and methods for therapy with dengue virus |
| AU2018283957B2 (en) * | 2017-06-12 | 2024-01-25 | Cleveland Clinic Lerner Research Institute | ZIKA virus strains for treatment of glioblastoma |
| EP3638303A4 (en) * | 2017-06-15 | 2021-03-10 | Primevax Immuno-Oncology, Inc. | COMPOSITIONS AND METHODS FOR CARCINOTHERAPY USING DENGUE AND DENDRITIC CELL VIRUS |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1015972A (en) | 1905-09-25 | 1912-01-30 | Westinghouse Electric & Mfg Co | Electric switch. |
| US1035755A (en) | 1908-07-21 | 1912-08-13 | Glenn S Smith | Draftsman's apparatus. |
| US6429199B1 (en) | 1994-07-15 | 2002-08-06 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules for activating dendritic cells |
| JP2002504322A (ja) * | 1998-02-20 | 2002-02-12 | ザ ロックフェラー ユニバーシティー | 樹状細胞に対するアポトーシス細胞介在抗原提示 |
| US6524587B1 (en) * | 1998-05-05 | 2003-02-25 | Bruce W. Lyday | Hyperthermia and immunotherapy for leukemias lymphomas, and solid tumors |
| US6048686A (en) | 1998-05-05 | 2000-04-11 | Randy Kyle Brown | Hyperthermia and immunotherapy for cancer |
| JP2002540168A (ja) | 1999-03-26 | 2002-11-26 | ウォルター リード アーミー インスティテュート オブ リサーチ | 多価デングウイルスワクチン |
| CA2365411A1 (en) * | 1999-03-26 | 2000-10-05 | Walter Reed Army Institute Of Research | Attenuated dengue-2 virus vaccine |
| JP2002539805A (ja) | 1999-03-31 | 2002-11-26 | ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケーション | 樹状細胞・腫瘍細胞または樹状細胞・ウイルス細胞由来免疫原を用いた抗原特異的ｔ細胞のインビトロ産生 |
| EP1484064A1 (en) | 2003-06-04 | 2004-12-08 | Gesellschaft für Biotechnologische Forschung | Therapeutical composition containing dentritic cells and use thereof |
| CN101006171A (zh) * | 2004-06-24 | 2007-07-25 | 株式会社载体研究所 | 含有单链负链rna病毒的抗癌剂 |
| US8513008B2 (en) | 2004-10-07 | 2013-08-20 | Argos Therapeutics, Inc. | Mature dendritic cell compositions and methods for culturing same |
| EP1882031B1 (en) * | 2005-04-08 | 2017-11-08 | Argos Therapeutics, Inc. | Dendritic cell compositions and methods |
| EP2589602B1 (en) | 2006-08-15 | 2016-04-06 | The Government of the U.S.A., as repr. by the Secretary, Dept. of Health & Human Services, the Nat. Inst. of Health | Development of dengue virus vaccine components |
| US8097256B2 (en) * | 2006-09-28 | 2012-01-17 | Cedars-Sinai Medical Center | Cancer vaccines and vaccination methods |
| CN102933228A (zh) | 2010-03-15 | 2013-02-13 | 宾夕法尼亚大学董事会 | 制备和储存活化的、成熟树突细胞的体系和方法 |
| PH12013502442A1 (en) | 2011-05-26 | 2018-03-21 | Glaxo Smithkline Biologicals Sa | Inactivated dengue virus vaccine |
| EP2543386A1 (en) * | 2011-07-05 | 2013-01-09 | Sotio a.s. | Means and methods for active cellular immunotherapy of cancer by using tumor cells killed by high hydrostatic pressure |
| US9879003B2 (en) | 2012-04-11 | 2018-01-30 | Dana-Farber Cancer Institute, Inc. | Host targeted inhibitors of dengue virus and other viruses |
| EP2858668A1 (en) * | 2012-06-10 | 2015-04-15 | Takeda Vaccines, Inc. | Compositions and methods for administration of vaccines against dengue virus |
| EA035259B1 (ru) | 2014-02-14 | 2020-05-21 | Иммьюн Дизайн Корп. | Иммунотерапия рака с применением комбинации местной и системной иммунной стимуляции |
| EP3291821B1 (en) | 2015-05-07 | 2026-02-25 | Baylor College of Medicine | Dendritic cell immunotherapy |
| WO2017004567A1 (en) | 2015-07-02 | 2017-01-05 | PrimeVax Immuno-Oncology, Inc. | Compositions and methods for combination therapy with dengue virus and dendritic cells |
| MX2018003757A (es) | 2015-09-26 | 2018-09-21 | Primevax Immuno Oncology Inc | Composiciones y metodos para producir celulas dendriticas. |
| WO2018093907A1 (en) | 2016-11-16 | 2018-05-24 | PrimeVax Immuno-Oncology, Inc. | Combination immunotherapies for treatment of cancer |
| WO2018129202A1 (en) | 2017-01-04 | 2018-07-12 | PrimeVax Immuno-Oncology, Inc. | Compositions and methods for therapy with dengue virus |
| EP3638303A4 (en) | 2017-06-15 | 2021-03-10 | Primevax Immuno-Oncology, Inc. | COMPOSITIONS AND METHODS FOR CARCINOTHERAPY USING DENGUE AND DENDRITIC CELL VIRUS |
-
2016
- 2016-07-01 WO PCT/US2016/040787 patent/WO2017004567A1/en not_active Ceased
- 2016-07-01 JP JP2017568234A patent/JP2018522880A/ja active Pending
- 2016-07-01 EP EP16818917.3A patent/EP3316897A4/en not_active Withdrawn
- 2016-07-01 DE DE202016008300.8U patent/DE202016008300U1/de not_active Expired - Lifetime
- 2016-07-01 US US15/200,751 patent/US9730989B2/en not_active Expired - Fee Related
- 2016-07-01 CN CN201680050897.6A patent/CN107921063A/zh active Pending
- 2016-07-01 CA CA2991212A patent/CA2991212A1/en not_active Abandoned
- 2016-07-01 MX MX2018000052A patent/MX2018000052A/es unknown
-
2017
- 2017-06-30 US US15/639,632 patent/US9849167B2/en not_active Expired - Fee Related
- 2017-10-31 US US15/799,793 patent/US10159727B2/en active Active
-
2018
- 2018-10-26 US US16/172,487 patent/US10357553B2/en not_active Expired - Fee Related
-
2019
- 2019-04-19 US US16/389,445 patent/US10946080B2/en not_active Expired - Fee Related
-
2021
- 2021-02-02 US US17/165,270 patent/US20210187086A1/en not_active Abandoned
- 2021-07-08 JP JP2021113634A patent/JP2021176862A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018522880A5 (enExample) | ||
| JP2016531927A5 (enExample) | ||
| MX2022006107A (es) | Metodos y composiciones para dosificacion en terapia celular adoptiva. | |
| WO2015193359A3 (en) | Novel immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (cll) | |
| MA39907A (fr) | Nouvelle immunothérapie contre plusieurs tumeurs, du sang, notamment la leucémie aiguë myéloïde (lam) | |
| JP2013177430A5 (enExample) | ||
| WO2015013461A3 (en) | Cancer vaccination with antigen evolution | |
| JP2015131795A5 (enExample) | ||
| NZ616304A (en) | Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses | |
| PH12021551208A1 (en) | Novel immunotherapy against several tumors, such as lung cancer, including nsclc | |
| PH12015502638A1 (en) | Novel immunotherapy against several tumors, such as lung cancer, including nsclc | |
| GB0700058D0 (en) | Anti-tumor vaccine based on normal cells | |
| NZ711946A (en) | Newcastle disease viruses and uses thereof | |
| MX379423B (es) | Inmunoterapia personalizada contra diversos tumores cerebrales y neuronales. | |
| MX376066B (es) | Anticuerpos dirigidos contra cd127. | |
| BR112013031084A2 (pt) | meios e métodos para imunoterapia celular ativa de câncer usando células tumorais mortas por alta pressão hidrostática e células dendríticas | |
| WO2016073595A8 (en) | T cells and dendritic cells for polyomavirus therapy | |
| RU2014117707A (ru) | Способ лечения пролиферативного заболевания | |
| CN104245736A (zh) | 抗人死亡受体5胞外区的人源化单克隆抗体 | |
| EA201790223A1 (ru) | Водный препарат, содержащий парацетамол и ибупрофен | |
| MX2021003826A (es) | Benralizumab para usarse en el tratamiento de asma incrementando el volumen espiratorio forzado. | |
| MX385304B (es) | Nuevos complejos metálicos de nocardamina y su uso en composiciones farmacéuticas. | |
| CY1115803T1 (el) | Μεσα και μεθοδοι ενεργης κυτταρικης ανοσοθεραπειας εναντι καρκινου χρησιμοποιωντας κυτταρα ογκου θανατωμενα υπο μεγαλη υδροστατικη πιεση και δενδριτικα κυτταρα | |
| WO2017041092A3 (en) | Anti-survivin antibodies for cancer therapy | |
| PH12016502008A1 (en) | Novel immunotherapy against several tumors of the blood, such as acute myeloid lukemia (aml) |